Helicos Hires Investment Bank to Advise on 'Strategic Alternatives,' Clarifies Instrument Placements | GenomeWeb

This article, originally published Sept. 3, has been updated with additional information.

By Julia Karow

Helicos BioSciences said last week that it has hired Thomas Weisel Partners "to assist the company with its evaluation and execution of strategic alternatives."

The company also clarified the number of instruments it has installed, as well as which of those instruments have been purchases as opposed to evaluation placements.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.